NeoBOMB1Alternative Names: 177Lu-NeoBOMB1; 68Ga-NeoBOMB1
Latest Information Update: 18 Oct 2016
At a glance
- Originator Erasmus University Rotterdam; National Center for Scientific Research Demokritos
- Class Imaging agents; Neuropeptides; Organometallic compounds; Peptides; Radioisotopes; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Bombesin receptor antagonists; Ionising radiation emitters; Neuropeptide receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Clinical Phase Unknown Prostate cancer